Features | ICH | Ischaemic |
Clinical progression | Slow progression to maximal neurological deficit | Maximal neurological deficit at onset |
Clinical symptom | Severe H/A (most often 1st symptoms), vomiting and alterations in consciousness |
- RCT
- Low dose Aspirin
- Placebo
- Above 70s
- 38% increase of haemorrhagic stroke or subdural, extradural, and subarachnoid bleeding
- No difference in incidence of ischemic stroke
- Rebleeding risk after 1st bleed around 4%
- Cerebral blood flow is maintained at a constant rate between mean arterial pressures of 50 - 150 mmHg BUT IT IS 10mmg Higher for cerebral prefusion pressure 60-160mmHg
Algorithm for determining revascularization procedures in cases in which parent artery occlusion is required
Intervention | Selection Criteria |
PAO w/out bypass | BTO†: no evidence of failure to tolerate occlusion; SPECT: no perfusion abnormality |
PAO w/ low-flow bypass (EC-IC) | BTO: no evidence of failure to tolerate occlusion on angiography or clinically during normotensive condition; failure to tolerate occlusion on clinical testing in hypotensive state, w/ or w/out abnormal EEG changes; SPECT: no perfusion abnormality |
PAO w/ high-flow bypass (vein or radial artery) | BTO: failure to tolerate occlusion in all tests; SPECT: asymmetrical perfusion |